Cargando…
Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis()
BACKGROUND: Discrepant data were reported about hospital admissions for ST-segment elevation myocardial infarction (STEMI) during COVID-19 pandemic. We reviewed studies reporting STEMI hospitalizations during COVID-19 pandemic, investigating whether differences in COVID-19 epidemiology or public hea...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561779/ https://www.ncbi.nlm.nih.gov/pubmed/34740717 http://dx.doi.org/10.1016/j.ijcard.2021.10.156 |
_version_ | 1784593148376252416 |
---|---|
author | Sofi, Francesco Dinu, Monica Reboldi, GianPaolo Stracci, Fabrizio Pedretti, Roberto F.E. Valente, Serafina Gensini, GianFranco Gibson, C. Michael Ambrosio, Giuseppe |
author_facet | Sofi, Francesco Dinu, Monica Reboldi, GianPaolo Stracci, Fabrizio Pedretti, Roberto F.E. Valente, Serafina Gensini, GianFranco Gibson, C. Michael Ambrosio, Giuseppe |
author_sort | Sofi, Francesco |
collection | PubMed |
description | BACKGROUND: Discrepant data were reported about hospital admissions for ST-segment elevation myocardial infarction (STEMI) during COVID-19 pandemic. We reviewed studies reporting STEMI hospitalizations during COVID-19 pandemic, investigating whether differences in COVID-19 epidemiology or public health-related factors could explain discrepant findings in different countries. METHODS: Search through MedLine, Embase, Scopus, Web-of-Science, Cochrane Register of Controlled Trials, of studies comparing STEMI admissions during COVID-19 pandemic with a reference period, without language restrictions, as registered in PROSPERO International Prospective Register of Systematic Reviews. Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines were followed. Data independently extracted by multiple investigators were pooled using a random-effects model. Health-related metrics were from publicly-available sources. RESULTS: We included 79 articles (111,557 STEMI cases, from 57 countries). During peak COVID-19 pandemic, overall incidence rate-ratio (IRR) of STEMI hospitalizations over reference period decreased (0.80; 95% CI 0.76–0.84; p < 0.05). Although wide variations and significant heterogeneity were detected among studies (I(2) = 89%; p < 0.0001), no significant differences were observed by report methodology (survey vs registry), or observation/reference period. However, large differences emerged at country level not explained by COVID-related epidemiological data, nor by public health strategies. Instead, IRRs for STEMI admissions were inversely related to hospital bed availability in each country (p < 0.05). CONCLUSIONS: During COVID-19 pandemic hospitalization for STEMI significantly decreased, although to a smaller extent than initially reported. Large variability emerged across countries, unrelated to COVID-related epidemiology or social containment measures. Disparities in healthcare organization likely contributed, indicating that proper organization of emergency medicine should be preserved during pandemics. |
format | Online Article Text |
id | pubmed-8561779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85617792021-11-02 Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() Sofi, Francesco Dinu, Monica Reboldi, GianPaolo Stracci, Fabrizio Pedretti, Roberto F.E. Valente, Serafina Gensini, GianFranco Gibson, C. Michael Ambrosio, Giuseppe Int J Cardiol Article BACKGROUND: Discrepant data were reported about hospital admissions for ST-segment elevation myocardial infarction (STEMI) during COVID-19 pandemic. We reviewed studies reporting STEMI hospitalizations during COVID-19 pandemic, investigating whether differences in COVID-19 epidemiology or public health-related factors could explain discrepant findings in different countries. METHODS: Search through MedLine, Embase, Scopus, Web-of-Science, Cochrane Register of Controlled Trials, of studies comparing STEMI admissions during COVID-19 pandemic with a reference period, without language restrictions, as registered in PROSPERO International Prospective Register of Systematic Reviews. Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines were followed. Data independently extracted by multiple investigators were pooled using a random-effects model. Health-related metrics were from publicly-available sources. RESULTS: We included 79 articles (111,557 STEMI cases, from 57 countries). During peak COVID-19 pandemic, overall incidence rate-ratio (IRR) of STEMI hospitalizations over reference period decreased (0.80; 95% CI 0.76–0.84; p < 0.05). Although wide variations and significant heterogeneity were detected among studies (I(2) = 89%; p < 0.0001), no significant differences were observed by report methodology (survey vs registry), or observation/reference period. However, large differences emerged at country level not explained by COVID-related epidemiological data, nor by public health strategies. Instead, IRRs for STEMI admissions were inversely related to hospital bed availability in each country (p < 0.05). CONCLUSIONS: During COVID-19 pandemic hospitalization for STEMI significantly decreased, although to a smaller extent than initially reported. Large variability emerged across countries, unrelated to COVID-related epidemiology or social containment measures. Disparities in healthcare organization likely contributed, indicating that proper organization of emergency medicine should be preserved during pandemics. The Authors. Published by Elsevier B.V. 2022-01-15 2021-11-02 /pmc/articles/PMC8561779/ /pubmed/34740717 http://dx.doi.org/10.1016/j.ijcard.2021.10.156 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Sofi, Francesco Dinu, Monica Reboldi, GianPaolo Stracci, Fabrizio Pedretti, Roberto F.E. Valente, Serafina Gensini, GianFranco Gibson, C. Michael Ambrosio, Giuseppe Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() |
title | Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() |
title_full | Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() |
title_fullStr | Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() |
title_full_unstemmed | Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() |
title_short | Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() |
title_sort | worldwide differences of hospitalization for st-segment elevation myocardial infarction during covid-19: a systematic review and meta-analysis() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561779/ https://www.ncbi.nlm.nih.gov/pubmed/34740717 http://dx.doi.org/10.1016/j.ijcard.2021.10.156 |
work_keys_str_mv | AT sofifrancesco worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis AT dinumonica worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis AT reboldigianpaolo worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis AT straccifabrizio worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis AT pedrettirobertofe worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis AT valenteserafina worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis AT gensinigianfranco worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis AT gibsoncmichael worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis AT ambrosiogiuseppe worldwidedifferencesofhospitalizationforstsegmentelevationmyocardialinfarctionduringcovid19asystematicreviewandmetaanalysis |